Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Struggling to keep your mid-month budget on track? Learn practical steps to identify overspending, reallocate funds, and implement quick tweaks that stabilize your finances.
23,349 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Marvell Technology has staged a decisive run in 2026, outpacing Broadcom in the AI accelerator stock race. As data-ce...
As retirement tax planning evolves in 2026, a roth conversion strategy that pairs careful timing with residency moves...
As markets swing and inflation cools, cash-rich utility retirees count on reliable, regulated cash flows. This report...
Curious about Cerebras stock and its three-year outlook? This guide breaks down growth drivers, risks, and three scen...
Micron Technology has unleashed a dramatic first half, but the market now eyes a cautious microns stock price predict...
Intel shares slipped about 6% in midday trading as HSBC boosted its price target 60% higher, while AMD and the broade...
A Trump-backed memecoin tumbled this week, erasing $3.81 billion in value and affecting nearly million wallets down. ...
Bitcoin has posted a three-quarter slide, raising questions about a possible late-year rebound. Analysts cite macro f...
Five years after a split investment in Bitcoin and XRP, the outcomes diverged dramatically amid regulation and instit...
As July 16 approaches, investors are weighing TSMC's Q2 results and what they mean for the stock. This article breaks...
Corporations are paying top dollar for battle-tested CFOs to steer turnarounds. Nike’s high-profile hire underscores ...